In some patients, the chronic inflammatory skin diseases psoriasis and eczema are so similar that dermatologists have had to examine tissue samples but a team of researchers at the Helmholtz Zentrum München and the Technical University of Munich (TUM) have now analyzed the molecular processes that occur in both diseases and discovered crucial differences.
This has enabled them to develop a diagnostic procedure which in practice enables psoriasis and eczema to be reliably differentiated from one another on the basis of only two genes.
Psoriasis is a non-contagious, inflammatory skin disease and can also be a systemic disease that affects other organs. It generally presents as very flaky patches of skin varying in size from spots to larger areas the size of one’s palms (frequently on the knees, the elbows and on the scalp, and also on the anus) – often with severe itching as well as nail changes. Worldwide about 125 million people suffer from it. Eczema is a skin disease that presents as a non-infectious inflammatory skin reaction and can be triggered by different factors. It is characterized by a typical sequence of skin reactions, such as reddening of the skin, blistering, weeping, scabbing, scaling.
“Both diseases have a highly complex appearance, which often varies widely from one patient to another,” says Dr. Stefanie Eyerich, who heads the Specific Immunology working group at the Institute of Allergy Research (IAF) at the Helmholtz Zentrum München. “This has led previous attempts to compare their molecular signature to fail.” In this study, the researchers identified 24 patients who were suffering simultaneously from psoriasis and eczema and in each analyzed at the molecular level the characteristic differences they demonstrated between psoriasis and eczema compared to clinically unremarkable skin.
“We were thus able to drastically reduce random genetic or environmental influences and gain a detailed picture of the development of these two diseases,” explains Prof. Fabian Theis of the Institute of Computational Biology (ICB) at the Helmholtz Zentrum München.
Paving the way for personalized medicine
In recent years, many new specific treatments have been developed for psoriasis and eczema. However, in each case, these are only effective for one or other of the two diseases. And they are very expensive: one such treatment generally costs several tens of thousands of euros per year, per patient. The ability to make an exact diagnosis therefore has a considerable economic impact.
If it cannot be clearly determined on presentation which of the two diseases is involved, the newly developed diagnostic tool will help to differentiate them. It involves a test which compares samples of diseased and healthy skin and is concluded within one day. The researchers have now filed a patent application for it.
The procedure, moreover, marks the first step towards the introduction of personalized medicine also for chronic inflammatory skin diseases. “Whereas this is practiced increasingly in oncology, for example in the form of mutation analyses and the subsequent decision in favor of the best individual treatment option, it is not common in the case of inflammatory skin diseases,” says Kilian Eyerich of the Clinic and Polyclinic for Dermatology at the Technical University of Munich.
The researchers plan to purse this path with a view to characterizing even more precisely the molecular processes involved in inflammatory skin diseases and combining them with clinical information, such as the choice of certain treatments. In this way, their goal is to determine the best possible treatment option for each individual patient.
Quaranta, M. et al, (2014), Intra-individual genome expression analysis reveals a specific molecular signature of psoriasis and eczema, Sci Transl Med, 2014 July 9th; Vol. 6, Issue 244, p. 244ra90; Sci. Transl. Med. DOI: 10.1126. Source: Helmholtz Zentrum Muenchen
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Suggestion: The EM Drive Is Getting The Appropriate Level Of Attention From The Science Community
- Animal Sex Is Spicier Than We Thought
- Will Aspartame Critics Now Be Less Bitter?
- Review Claims Link Between Wireless Devices And Cancer
- Wind Energy Subsidies Boost It To 8 Percent Of Europe's Electricity
- Kenya Example: How Re-Analyzing Scientific Research Data Can Change The Findings
- Bang! Meet The Highest-Energy Hadron Collision Ever Imaged!
- "With Tesla's home and office Powerwalls and the utility scale Powerpacks are fully built in Europe..."
- "2,000 contributors is not a crowd? ..."
- "Contrary to what you have written above, the SEC is not crowdsourced. See the Stanford Report:..."
- "Boob-ayCongratulations. You have made in into a select list of imbeciles: those who cannot read..."
- "Quite aside from the fact that your arithmetic is horrid, your chemistry is even worse. When a..."
- Excessive or inadequate? Confusion about medication is common
- Breast cancer in young women is rarer than media make it seem
- GE crops could save the environment, if Organic advocates let them
- No excuses to be against science now: Monsanto patent expires
- The Pendulum Swings: Prescribing Hormone Replacement Therapy 13 Years After the Women’s Health Initiative Study
- The search for new blood donors ends at the living – but why?
- How not to convince vaccine skeptics
- Even a little weekly physical activity goes a long way for seniors
- Low levels of endocrine disruptors in the environment may cause sex reversal in female frogs
- Get up for your heart health and move for your waistline
- As biodiversity declines on corn farms, pest problems grow
Books By Writers Here